Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

INTRODUCTION: Chemotherapy (CT) is commonly used as an adjuvant treatment for women with early breast cancer (BC). However, not all patients benefit from CT, while all are exposed to its short- and long-term toxicity. The Oncotype DX(®) test assesses cancer-related gene expression to estimate the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtit, Elsa, Bellanger, Martine Marie, Nerich, Virginie, Hequet, Delphine, Frenel, Jean-Sebastien, Cristeau, Olivier, Rouzier, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327821/
https://www.ncbi.nlm.nih.gov/pubmed/37427133
http://dx.doi.org/10.3389/fonc.2023.1191943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327821/
https://www.ncbi.nlm.nih.gov/pubmed/37427133
http://dx.doi.org/10.3389/fonc.2023.1191943

Ejemplares similares